INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

GSKGSK plc

10% OwnerCIK 0001131399

EDGAR filingsOpen in network
Disclosed transactions1
Buys / sells1 / 0
Max Insider Score45
Connections12with evidence

GSK · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
45
GSK plc10% Owner
WVEWave Life Sciences, Inc.
Open-market purchase
BUY$27.93M
1.47M sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Connected organizationevidence
    GLAXOSMITHKLINE LLC PAC (GSK PAC)FEC Form 1 connected organization: GLAXOSMITHKLINE LLC (curated map) · Nov 4, 2026
  • ← Lobbied forevidence
    SIMS STRATEGIES, LLCLDA Q1 2026 first quarter · Pharmacy, Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    W STRATEGIES, LLCLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    CHECKMATE GOVERNMENT RELATIONSLDA Q2 2026 second quarter · Health issues, Pharmacy · Aug 26, 2026
  • ← Lobbied forevidence
    MARSHALL & POPP, LLCLDA RR 2026 first quarter · Pharmacy, Trade · Aug 26, 2026
  • ← Lobbied forevidence
    TODD STRATEGY GROUPLDA Q1 2026 first quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    ALPINE GROUP PARTNERS, LLC.LDA Q1 2026 first quarter · Budget/appropriations, Medicare/Medicaid, Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    CAPITOL COUNSEL LLCLDA Q2 2026 second quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    BGR GOVERNMENT AFFAIRSLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    LMH STRATEGIC SOLUTIONSLDA Q2 2026 second quarter · Health issues, Pharmacy · Aug 26, 2026
  • Insider ofevidence
    Wave Life Sciences, Inc.10% Owner · Dec 15, 2025

    • Lobbying

    $850K reported · de-duplicated
    2026 Q2 $440K via firms2026 Q1 $410K via firms
    • W STRATEGIES, LLC$40K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid
    • SIMS STRATEGIES, LLC$40K2026 Q1 · posted Aug 26, 2026 · Pharmacy, Medicare/Medicaid
    • CHECKMATE GOVERNMENT RELATIONS$60K2026 Q1 · posted Aug 26, 2026 · Health issues, Pharmacy
    • LMH STRATEGIC SOLUTIONS$50K2026 Q1 · posted Aug 26, 2026 · Health issues, Pharmacy
    • W STRATEGIES, LLC$40K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid
    • MARSHALL & POPP, LLC$50K2026 Q2 · posted Aug 26, 2026 · Pharmacy
    • BGR GOVERNMENT AFFAIRS$60K2026 Q2 · posted Aug 26, 2026 · Health issues
    • TODD STRATEGY GROUP$60K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
    • MARSHALL & POPP, LLC$20K2026 Q1 · posted Aug 26, 2026 · Pharmacy
    • ALPINE GROUP PARTNERS, LLC.$30K2026 Q2 · posted Aug 26, 2026 · Budget/appropriations, Medicare/Medicaid, Health issues
    • LMH STRATEGIC SOLUTIONS$50K2026 Q2 · posted Aug 26, 2026 · Health issues, Pharmacy
    • CAPITOL COUNSEL LLC$50K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid

    Connected PAC contributions

    FEC · direct to members
    • Brett GuthrieR$6,500GLAXOSMITHKLINE LLC PAC (GSK PAC)
    • Steve ScaliseR$6,000GLAXOSMITHKLINE LLC PAC (GSK PAC)
    • Ted BuddR$6,000GLAXOSMITHKLINE LLC PAC (GSK PAC)
    • Roger MarshallR$6,000GLAXOSMITHKLINE LLC PAC (GSK PAC)
    • Steve DainesR$5,000GLAXOSMITHKLINE LLC PAC (GSK PAC)
    Deborah K. RossD
    $5,000
    GLAXOSMITHKLINE LLC PAC (GSK PAC)
  • Katherine M. ClarkD$5,000GLAXOSMITHKLINE LLC PAC (GSK PAC)
  • Mike JohnsonR$5,000GLAXOSMITHKLINE LLC PAC (GSK PAC)
  • John JoyceR$4,500GLAXOSMITHKLINE LLC PAC (GSK PAC)
  • Richard HudsonR$3,500GLAXOSMITHKLINE LLC PAC (GSK PAC)
  • Diana DeGetteD$3,500GLAXOSMITHKLINE LLC PAC (GSK PAC)
  • Donald G. DavisD$3,500GLAXOSMITHKLINE LLC PAC (GSK PAC)